Filters: author is Bueters [Clear All Filters]
- 2003
Characterization of the pharmacokinetics, brain distribution, and therapeutic efficacy of the adenosine A1 receptor partial agonist 2'-deoxy-N6-cyclopentyladenosine in sarin-poisoned rats,
Toxicol Appl Pharmacol, vol. 192, no. 1, pp. 86-94. DOI
Cyclopentyladenosine and some of its low-efficacy derivatives inhibit striatal synaptosomal release of acetylcholine to a similar degree,
Eur J Pharmacol, vol. 481, no. 2-3, pp. 141-6. DOI
Low efficacy adenosine A1 agonists inhibit striatal acetylcholine release in rats improving central selectivity of action,
Neurosci Lett, vol. 343, no. 1, pp. 57-61. DOI
Adenosine A1 receptor agonist N6-cyclopentyladenosine affects the inactivation of acetylcholinesterase in blood and brain by sarin,
J Pharmacol Exp Ther, vol. 304, no. 3, pp. 1307-13. DOI
- 2002
Effects of the adenosine A1 receptor allosteric modulators PD 81,723 and LUF 5484 on the striatal acetylcholine release,
Eur J Pharmacol, vol. 454, no. 2-3, pp. 177-82. DOI
Therapeutic efficacy of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) against organophosphate intoxication,
Arch Toxicol, vol. 76, no. 11, pp. 650-6. DOI


